Case Reports
doi: 10.1111/j.1600-0609.2007.00994.x.
Epub 2007 Nov 15.
Three cases of Pneumocystis jirovecii pneumonia (PCP) during first-line treatment with rituximab in combination with CHOP-14 for aggressive B-cell non-Hodgkin's lymphoma
- PMID: 18005387
- DOI: 10.1111/j.1600-0609.2007.00994.x
Item in Clipboard
Case Reports
Three cases of Pneumocystis jirovecii pneumonia (PCP) during first-line treatment with rituximab in combination with CHOP-14 for aggressive B-cell non-Hodgkin's lymphoma
Eur J Haematol.
2008 Mar.
No abstract available
Similar articles
-
The incidence of Pneumocystis jirovecii pneumonia is not higher in patients receiving dose-dense therapy with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine, and prednisolone and adequate Pneumocystis jirovecii pneumonia prophylaxis.Leuk Lymphoma. 2011 Jan;52(1):148-9. doi: 10.3109/10428194.2010.525726. Epub 2010 Nov 11. Leuk Lymphoma. 2011. PMID: 21067442 No abstract available.
-
Two cases of Pneumocystis jiroveci pneumonia with non-Hodgkin's lymphoma after CHOP-based chemotherapy containing rituximab.J Clin Exp Hematop. 2010;50(2):159-62. doi: 10.3960/jslrt.50.159. J Clin Exp Hematop. 2010. PMID: 21123974
-
The increased risk for pneumocystis pneumonia in patients receiving rituximab-CHOP-14 can be prevented by the administration of trimethoprim/sulfamethoxazole: a single-center experience.Acta Haematol. 2012;127(2):110-4. doi: 10.1159/000334113. Epub 2011 Dec 16. Acta Haematol. 2012. PMID: 22178955
-
Progressive multifocal leukoencephalopathy in a patient with B-cell lymphoma during rituximab-containing chemotherapy: case report and review of the literature.Int J Hematol. 2008 Nov;88(4):443-447. doi: 10.1007/s12185-008-0168-2. Epub 2008 Oct 15. Int J Hematol. 2008. PMID: 18855101 Review.
-
Primary adrenal lymphoma presenting as adrenal insufficiency. A case report and review of literature.Conn Med. 2004 Jan;68(1):7-10. Conn Med. 2004. PMID: 14752912 Review.
Cited by
-
Hypogammaglobulinemia, late-onset neutropenia, and infections following rituximab.Ann Allergy Asthma Immunol. 2023 Jun;130(6):699-712. doi: 10.1016/j.anai.2023.01.018. Epub 2023 Jan 24. Ann Allergy Asthma Immunol. 2023. PMID: 36706910 Free PMC article. Review.
-
Pneumocystis pneumonia in patients treated with rituximab.Chest. 2013 Jul;144(1):258-265. doi: 10.1378/chest.12-0477. Chest. 2013. PMID: 23258406 Free PMC article.
-
Should Pneumocystis jiroveci prophylaxis be recommended with Rituximab treatment in ANCA-associated vasculitis?Clin Rheumatol. 2013 Nov;32(11):1677-81. doi: 10.1007/s10067-013-2293-4. Epub 2013 Jun 11. Clin Rheumatol. 2013. PMID: 23754241
-
IL-4 polymorphism influences susceptibility to Pneumocystis jirovecii pneumonia in HIV-positive patients.AIDS. 2019 Sep 1;33(11):1719-1727. doi: 10.1097/QAD.0000000000002283. AIDS. 2019. PMID: 31225812 Free PMC article.
-
Pneumocystis jiroveci pneumonia in patients with non-Hodgkin's lymphoma after Rituximab-containing regimen: two cases of report and literature review.J Thorac Dis. 2013 Aug;5(4):E162-6. doi: 10.3978/j.issn.2072-1439.2013.08.35. J Thorac Dis. 2013. PMID: 23991330 Free PMC article.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Research Materials
